Literature DB >> 17005799

Resistance of Yersinia pestis to antimicrobial agents.

Marc Galimand1, Elisabeth Carniel, Patrice Courvalin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17005799      PMCID： PMC1610074          DOI： 10.1128/AAC.00306-06

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  24 in total

1.  Susceptibility of Yersinia pestis to novel and conventional antimicrobial agents.

Authors:  John Frean; Keith P Klugman; Lorraine Arntzen; Stanley Bukofzer
Journal:  J Antimicrob Chemother       Date:  2003-07-15       Impact factor: 5.790

Review 2.  From the recent lessons of the Malagasy foci towards a global understanding of the factors involved in plague reemergence.

Authors:  Jean-Marc Duplantier; Jean-Bernard Duchemin; Suzanne Chanteau; Elisabeth Carniel
Journal:  Vet Res       Date:  2005 May-Jun       Impact factor: 3.683

3.  Multidrug resistance in Yersinia pestis mediated by a transferable plasmid.

Authors:  M Galimand; A Guiyoule; G Gerbaud; B Rasoamanana; S Chanteau; E Carniel; P Courvalin
Journal:  N Engl J Med       Date:  1997-09-04       Impact factor: 91.245

4.  Current epidemiology of human plague in Madagascar.

Authors:  S Chanteau; M Ratsitorahina; L Rahalison; B Rasoamanana; F Chan; P Boisier; D Rabeson; J Roux
Journal:  Microbes Infect       Date:  2000-01       Impact factor: 2.700

5.  Bichat guidelines for the clinical management of plague and bioterrorism-related plague.

Authors:  Philippe Bossi; Anders Tegnell; Agoritsa Baka; Frank Van Loock; Jan Hendriks; Albrecht Werner; Heinrich Maidhof; Georgios Gouvras
Journal:  Euro Surveill       Date:  2004-12-15

6.  Efficacy of the latest fluoroquinolones against experimental Yersinia pestis.

Authors:  J Steward; M S Lever; P Russell; R J Beedham; A J Stagg; R R Taylor; T J G Brooks
Journal:  Int J Antimicrob Agents       Date:  2004-12       Impact factor: 5.283

Review 7.  Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes.

Authors:  K J Shaw; P N Rather; R S Hare; G H Miller
Journal:  Microbiol Rev       Date:  1993-03

8.  A case of plague successfully treated with ciprofloxacin and sympathetic blockade for treatment of gangrene.

Authors:  T Kuberski; L Robinson; A Schurgin
Journal:  Clin Infect Dis       Date:  2003-01-29       Impact factor: 9.079

9.  Antibiotic susceptibilities of 94 isolates of Yersinia pestis to 24 antimicrobial agents.

Authors:  Eric Hernandez; Monique Girardet; Francoise Ramisse; Dominique Vidal; Jean-Didier Cavallo
Journal:  J Antimicrob Chemother       Date:  2003-11-12       Impact factor: 5.790

10.  Gentamicin and tetracyclines for the treatment of human plague: review of 75 cases in new Mexico, 1985-1999.

Authors:  L Lucy Boulanger; Paul Ettestad; John D Fogarty; David T Dennis; Donald Romig; Gregory Mertz
Journal:  Clin Infect Dis       Date:  2004-02-17       Impact factor: 9.079
View more
  74 in total

1.  Structural insights into Ail-mediated adhesion in Yersinia pestis.

Authors:  Satoshi Yamashita; Petra Lukacik; Travis J Barnard; Nicholas Noinaj; Suleyman Felek; Tiffany M Tsang; Eric S Krukonis; B Joseph Hinnebusch; Susan K Buchanan
Journal:  Structure       Date:  2011-11-09       Impact factor: 5.006

2.  Yersinia effector YopO uses actin as bait to phosphorylate proteins that regulate actin polymerization.

Authors:  Wei Lin Lee; Jonathan M Grimes; Robert C Robinson
Journal:  Nat Struct Mol Biol       Date:  2015-02-09       Impact factor: 15.369

3.  Comparison of Etest method with reference broth microdilution method for antimicrobial susceptibility testing of Yersinia pestis.

Authors:  David R Lonsway; Sandra K Urich; Henry S Heine; Sigrid K McAllister; Shailen N Banerjee; Martin E Schriefer; Jean B Patel
Journal:  J Clin Microbiol       Date:  2011-03-16       Impact factor: 5.948

4.  One year immunogenicity and safety of subunit plague vaccine in Chinese healthy adults: An extended open-label study.

Authors:  Jialei Hu; Lei Jiao; Yuemei Hu; Kai Chu; Jingxin Li; Fengcai Zhu; Taishun Li; Zhiyuan Wu; Dong Wei; Fanyue Meng; Bingxiang Wang
Journal:  Hum Vaccin Immunother       Date:  2018-07-11       Impact factor: 3.452

5.  Low copy expression vectors for use in Yersinia sp. and related organisms.

Authors:  Markus W Obrist; Virginia L Miller
Journal:  Plasmid       Date:  2012-03-15       Impact factor: 3.466

6.  Structural Insights into the Yersinia pestis Outer Membrane Protein Ail in Lipid Bilayers.

Authors:  Samit Kumar Dutta; Yong Yao; Francesca M Marassi
Journal:  J Phys Chem B       Date:  2017-08-04       Impact factor: 2.991

7.  Lovastatin protects against experimental plague in mice.

Authors:  Saravanan Ayyadurai; Hubert Lepidi; Claude Nappez; Didier Raoult; Michel Drancourt
Journal:  PLoS One       Date:  2010-06-02       Impact factor: 3.240

8.  Rapid and sensitive detection of Yersinia pestis using amplification of plague diagnostic bacteriophages monitored by real-time PCR.

Authors:  Kirill V Sergueev; Yunxiu He; Richard H Borschel; Mikeljon P Nikolich; Andrey A Filippov
Journal:  PLoS One       Date:  2010-06-28       Impact factor: 3.240

9.  Development and application of the active surveillance of pathogens microarray to monitor bacterial gene flux.

Authors:  Richard A Stabler; Lisa F Dawson; Petra C F Oyston; Richard W Titball; Jim Wade; Jason Hinds; Adam A Witney; Brendan W Wren
Journal:  BMC Microbiol       Date:  2008-10-09       Impact factor: 3.605

Review 10.  Public health threat of new, reemerging, and neglected zoonoses in the industrialized world.

Authors:  Sally J Cutler; Anthony R Fooks; Wim H M van der Poel
Journal:  Emerg Infect Dis       Date:  2010-01       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.